Personalized organ dose assessment from CT imaging during proton therapy for classical Hodgkin lymphoma patients

Key Points

• Personalized dose assessment reveals significant variations in organ-specific radiation exposure during therapy.
• The analysis showed a 20% reduction in unnecessary radiation exposure in organs compared to standard protocols.
• CT imaging data was used to inform treatment planning, focusing on minimizing radiation risks for patients.
• These findings highlight the need for individualized approaches in proton therapy, enhancing patient safety.